Joinn Laboratories' (SHA:603127, HKG:6127) unit, JOINN Management Technology, subscribed to seven asset management products for a total of 540 million yuan, according to a Hong Kong bourse filing on Wednesday.
The drug research company's Hong Kong shares rose 2%, while Shanghai shares slipped 1% during Thursday's midday trade.
The company bought the asset management products from China Capital Management and CITIC Securities (SHA:600030, HKG:6030).
The products have a maturity date between October 2026 and March 2027, and their annual rate of return ranges from 1.4% to 4.65%.